About Us

Prostate cancer

Urothelial cancer


Functional Urology


Pediatric urology


Research Objectives

We investigate clinical, epidemiological, pathological, molecular and genetic characteristics of urological diseases. Our goal is to improve urological healthcare, from the general practitioner to tertiary academic care.


The Department of Urology of the Erasmus University Medical Center, Rotterdam, is embedded in the dynamic, internationally competitive research community of  several clinical, translational and basic research groups. Our focus lies in Protate Cancer, Urothelial Cancer, Functional Urology, Andrology and Pediatric Urology. We have longstandig collaborations with multiple other acadamic centers, both internationally and at a national level, and host fruitful relationships with our industry partners. Our department is renowed for participation at the highest level to improve European Patient Guidelines.

Academic Excellence

Our motto: “research” = care. We aim to improve the diagnosis, treatment and outcome in patients with urologic diseases by translational, clinical and epidemiological research, and education of students and professionals. Providing excellent academic care at a tertiary level is in our DNA. Do you want to be part of our team, either as as aspiring researcher or student, don’t hesitate to send your contact information to one of our Principal Investigators.

The Department of Urology is placed in the Staff Tower (Na buidling), the Erasmus MC Cancer Institute (Be building) and in the research tower (Ee building). The Department Chair is Dr. Joost L. Boormans.

Upcoming Events

Latest news

New publication: Impact of comedonecrosis on prostate cancer outcome: a systematic review

Kaveri T S Aiyer 1, Lisa J Kroon 1, Geert J L H van Leenders 1 Abstract Cribriform architecture has been recognised as an independent...
Read More

New publication: The Europa Uomo Patient Reported Outcome Study 2.0-Prostate Cancer Patient-reported Outcomes to Support Treatment Decision-making

Lionne D F Venderbos 1, Sebastiaan Remmers 2, André Deschamps 3, John Dowling 3, Ernst-Günter Carl 3, Nuno Pereira-Azevedo 4, Monique J Roobol 2 Abstract Background: To further strengthen the voice of patients, Europa...
Read More

Interview Amazing ErasmusMC NMIBC

Christiaan de Jong and Tahlita Zuiverloon were interviewed by Amazing ErasmusMC on their recently published study on non-muscle-invasive bladder cancer...
Read More

New publication: Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin

Florus C de Jong 1, Teemu D Laajala 2 3, Robert F Hoedemaeker 4, Kimberley R Jordan 5, Angelique C J van der Made 6, Egbert R Boevé 7, Deric K E van...
Read More

New publication: Differences between brain responses to peroneal electrical transcutaneous neuromodulation and transcutaneous tibial nerve stimulation, two treatments for overactive bladder

Jan Krhut 1 2, Jaroslav Tintěra 3, Michal Rejchrt 4, Barbora Skugarevská 1 2, Roman Zachoval 5, Peter Zvara 6 7, Bertil F M Blok 8   Abstract Objectives: To compare brain responses to peroneal electrical transcutaneous...
Read More

New publication: Shifting risk-stratified early prostate cancer detection to a primary healthcare setting

Renée Hogenhout 1, Daniël F Osses 1, Arnout R Alberts 1, Hanne G Buizer-Rijksen 2, Sebastiaan Remmers 1, Monique J Roobol 1 Abstract Objective: To evaluate the feasibility of multivariable risk stratification...
Read More

New publication: Active Surveillance for Prostate Cancer: Past, Current, and Future Trends

Ivo I de Vos 1, Henk B Luiting 1, Monique J Roobol 1 Abstract In response to the rising incidence of indolent, low-risk prostate cancer...
Read More

New publication: A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines

Joep J de Jong 1, Olga M Pijpers 2, Kim E M van Kessel 2, Joost L Boormans 2, Wim Van Criekinge 3, Ellen C Zwarthoff 4, Yair Lotan 5 Abstract Background: According...
Read More

New publication: Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

Sebastiaan Remmers, Monique J. Roobol, et al.  Abstract Background The European Association of Urology guidelines recommend a risk-based strategy for...
Read More

Article alert: Blaasspoelingen met Gemcitabine en Docetaxel als salvage therapie voor zeer hoog risico niet-spierinvasief blaaskanker patiënten

Olga Pijpers, Joost Boormans - This article continues in Dutch - Op de EAU (European Association of Urology) in Milaan...
Read More

New publication: Urinary Incontinence and Sexual Function After the Introduction of NeuroSAFE in Radical Prostatectomy for Prostate Cancer

Margaretha A van der Slot1, Sebastiaan Remmers2, Geert J L H van Leenders3, Martijn B Busstra4, Melanie Gan5, Sjoerd Klaver5, John B W Rietbergen6, Michael A den...
Read More

New publication: A Detailed Evaluation of the Effect of Prostate-specific Antigen–based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer

Ivo I de Vos 1, Annick Meertens 2, Renée Hogenhout 2, Sebastiaan Remmers 2, Monique J Roobol 2; ERSPC Rotterdam Study Group 2 Abstract Background Considering the long natural history of prostate...
Read More

New publication: Sexual and urinary function in prostate cancer clinical studies and the Europa Uomo Patient Reported Outcome Study: does it match?

Sebastiaan Remmers, Lionne D Venderbos , André Deschamps , John Dowling , Ernst-Günter Carl , Monique J Roobol  Abstract Background: We aimed to quantify the difference in patient reported outcome...
Read More

EAU 2023 Milan

Erasmus Urology research team at EAU 2023 At this year’s European Association of Urology congress in Milan, our team of...
Read More

New publication: The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam

Abstract Sebastiaan Remmers, Daan Nieboer, Monique J. Roobol Background The ERSPC study has demonstrated that prostate-specific antigen (PSA)-based screening results in...
Read More

New publication: Prostate cancer risk assessment by the primary care physician and urologist: transabdominal- versus transrectal ultrasound prostate volume-based use of the Rotterdam Prostate Cancer Risk Calculator

Abstract Ivo I de Vos 1, Frank-Jan H Drost 1, Leonard P Bokhorst 1, Arnout R Alberts 1, Martine van Gelder 2, Erik M Herman 3, Wouter D Boswinkel 4, Chris H Bangma 1, Monique J...
Read More

An interview with Dr. Joost Boormans; ‘Even plassen volstaat om blaaskanker uit te sluiten’

Dr. Joost Boormans, urologist and head of the Department of Urology at the Erasmus MC, was interviewed by DOQ about...
Read More

New publication: Interaction of MRI and active surveillance in prostate cancer: Time to re-evaluate the active surveillance inclusion criteria

Abstract Lionne Df Venderbos , Henk Luiting , Renée Hogenhout , Monique J Roobol  Currently available data from long-running single- and multi-center active surveillance (AS) studies...
Read More

One picture says more than a thousand words

-this article continues in Dutch- Uroloog Tahlita Zuiverloon (Erasmus MC Blaaskankercentrum) en projectleider Jozien Helleman zijn kartrekkers van de vernieuwde...
Read More

New publication: Androgen receptors in the forebrain: A study in adult male cats

Abstract Androgens and their receptors are present throughout the body. Various structures such as muscles, genitals, and prostate express androgen...
Read More


The full archive can be found by clicking here